Literature DB >> 18654097

In-hospital mortality and prognostic factors in patients admitted for new-onset heart failure with preserved or reduced ejection fraction: a prospective observational study.

C Tribouilloy1, D Rusinaru, L Leborgne, H Mahjoub, C Szymanski, D Houpe, M Béguin, M Peltier.   

Abstract

INTRODUCTION: Heart failure (HF) is associated with high morbidity and mortality. A significant component of HF-related adverse outcome occurs during hospitalization. Objective. - To assess features and in-hospital outcomes of patients hospitalized for a first episode of HF.
METHODS: We prospectively recruited 799 consecutive patients hospitalized for a first episode of HF during 2000 in the Somme department (France). We evaluated in-hospital mortality in this cohort, identified factors predictive for hospital death, and compared the mortality in patients with preserved or reduced ejection fraction (EF).
RESULTS: The mean age of the study population was 75+/-12 years. EF, assessed in 662 patients (83%), was preserved (> or = 50%) in 56% of cases. During hospitalization, 64 deaths (8%) were recorded. The major causes of in-hospital death were acute pulmonary oedema (50%) and cardiogenic shock (22%). Coronary artery disease, low systolic blood pressure on admission, increased heart rate on admission, renal failure, reduced EF (<50%) and older age were identified as independent predictors of in-hospital mortality. Patients with preserved EF were older and comprised a greater proportion of women. In-hospital mortality of the reduced EF group was higher than that of the preserved EF group (8.2% versus 2.7%, p=0.002). On multivariable analysis, reduced EF was independently associated with in-hospital death (odds ratio 2.32; 95% confidence interval 1.06-5.11; p=0.03). In propensity-matched patients, in-hospital mortality was higher in the reduced EF group (7.6% versus 2.2% p=0.02).
CONCLUSION: The in-hospital outcome of patients admitted for new-onset HF is poor. Patients with preserved EF are older but have lower in-hospital mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18654097     DOI: 10.1016/s1875-2136(08)73697-0

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  7 in total

1.  Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.

Authors:  Catherine N Marti; Gregg C Fonarow; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

Review 2.  Acute heart failure: patient characteristics and pathophysiology.

Authors:  Catherine N Marti; Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos
Journal:  Curr Heart Fail Rep       Date:  2013-12

3.  Pulmonary oedema, think beyond the heart even in the presence of severe left ventricular systolic dysfunction.

Authors:  Shohreh Honarbakhsh; Mohammad Chowdhury; Andrew Deaner; Fahad Farooqi
Journal:  BMJ Case Rep       Date:  2015-11-03

4.  Acute hypertensive pulmonary edema after Cesarean section in a patient with an antepartum myocardial infarction -A case report-.

Authors:  Sung Mee Jung; Eun Su Park; Young Su Lim; Chun Woo Yang; Keum Won Kim; Po Soon Kang
Journal:  Korean J Anesthesiol       Date:  2010-12-31

Review 5.  Mortality in heart failure patients.

Authors:  Ibadete Bytyçi; Gani Bajraktari
Journal:  Anatol J Cardiol       Date:  2014-08-19       Impact factor: 1.596

6.  Is the blood pressure paradox observed in all heart failure patients?

Authors:  F M Cunha; P Lourenço; M Couto; P Tavares; S Silva; J T Guimarães; P Bettencourt
Journal:  Biomed Res Int       Date:  2013-11-25       Impact factor: 3.411

7.  The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism.

Authors:  Qi Chen; Dini Zhang; Yunhui Bi; Weiwei Zhang; Yuhan Zhang; Qinghai Meng; Yu Li; Huimin Bian
Journal:  Chin Med       Date:  2020-06-15       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.